These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
92 related articles for article (PubMed ID: 24153022)
1. Safety of cidofovir by intratympanic delivery technique. Ward JA; Sidell DR; Nassar M; Reece AL; Choo DI Antivir Ther; 2014; 19(1):97-105. PubMed ID: 24153022 [TBL] [Abstract][Full Text] [Related]
2. Combination therapies using an intratympanic polymer gel delivery system in the guinea pig animal model: A safety study. Sidell D; Ward JA; Pordal A; Quimby C; Nassar M; Choo DI Int J Pediatr Otorhinolaryngol; 2016 May; 84():132-6. PubMed ID: 27063768 [TBL] [Abstract][Full Text] [Related]
3. The effect of cidofovir on cytomegalovirus-induced hearing loss in a Guinea pig model. White DR; Choo DI; Stroup G; Schleiss MR Arch Otolaryngol Head Neck Surg; 2006 Jun; 132(6):608-15. PubMed ID: 16785405 [TBL] [Abstract][Full Text] [Related]
4. Oral hexadecyloxypropyl-cidofovir therapy in pregnant guinea pigs improves outcome in the congenital model of cytomegalovirus infection. Bravo FJ; Bernstein DI; Beadle JR; Hostetler KY; Cardin RD Antimicrob Agents Chemother; 2011 Jan; 55(1):35-41. PubMed ID: 21078944 [TBL] [Abstract][Full Text] [Related]
5. Cidofovir as primary pre-emptive therapy for post-transplant cytomegalovirus infections. Chakrabarti S; Collingham KE; Osman H; Fegan CD; Milligan DW Bone Marrow Transplant; 2001 Nov; 28(9):879-81. PubMed ID: 11781649 [TBL] [Abstract][Full Text] [Related]